VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2015

May 21, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2015-05-19

Reporting Person: Kearney Terrence C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-19	Common Stock	M	1500	$56.99	Acquired	1500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-19	Stock Option (right to buy)	$56.99	M	1500	Disposed	2021-05-16	Common Stock (1500)	Direct

Footnotes

F1: Fully vested.